Tag: metastatic cervical cancer

Click here to read this study in The Lancet.  ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...

1. Cadonilimab plus chemotherapy significantly improved progression-free survival in patients with persistent, recurrent, or metastatic cervical cancer. 2. Common grade ...

1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival among patients with metastatic, persistent, or recurrent cervical cancer. ...

1. The overall response rate was 54.8% in the intention-to-treat group while it was 59.0% in the efficacy-evaluable group. 2. ...